Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RANOLAZINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for RANOLAZINE EXTENDED-RELEASE TABLETS. RANOLAZINE extended-release tablets, for oral use. Initial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.
- generic_name
- ranolazine
- product_names
- Ranolazine
- ndc
- 71205-867, 71205-868, 69367-293, 71205-867-30, 71205-867-60, 71205-867-90, 71205-867-00, 71205-867-72, 71205-867-78, 71205-867-55, 69367-294, 71205-868-30, 71205-868-60, 71205-868-90, 71205-868-00, 71205-868-72, 71205-868-78, 71205-868-55
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en